.png){kind=icon}
.png){kind=icon}
Return
The role of [18F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors
.png){kind=icon}
PRE
AI
K
N
T
K
N
DOI：10.1102/1470-7330.2011.0028.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
The purpose of this study was to systemically review the available literature regarding the diagnostic performance of positron emission tomography (PET) using 2-[F-18]fluoro-2-deoxy-D-glucose ([F-18]FDG) in patients with thymic epithelial tumors. We reviewed 13 studies that evaluated the diagnostic role of thymic epithelial tumors with [F-18]FDG-PET. [F-18]FDG-PET is a useful radiological modality for differentiating between thymomas and thymic carcinoma. However, [F-18]FDG-PET may not be useful for differentiating low-risk thymoma and high-risk thymoma. One paper reported that [F-18]FDG-PET has a predictive significance for treatment and prognosis in thymic epithelial tumors. Two papers reported that the degree of [F-18]FDG uptake in thymic epithelial tumors is based on glucose metabolism. [F-18]FDG-PET may have a further use for radiological differential diagnosis of thymomas and thymic carcinomas.
Keywords:
Thymic epithelial tumor
[F-18]FDG-PET
systemic review
differential diagnosis
Journal
IF:
3.5
Papers:
1.3K
Citations:
3.5K
Organization
Cited Papers